D-Index & Metrics Best Publications
Biology and Biochemistry
Australia
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 90 Citations 26,249 408 World Ranking 1589 National Ranking 39

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in Australia Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Enzyme

His scientific interests lie mostly in Nuclear transport, Nuclear localization sequence, Importin, Cell biology and Biochemistry. His Nuclear transport research is multidisciplinary, incorporating perspectives in Molecular biology, Nuclear pore and Virology. His Nuclear localization sequence study incorporates themes from Nuclear protein, Transcription factor and Fusion protein.

David A. Jans has included themes like Parathyroid hormone-related protein, Nucleoporin, Beta Karyopherins, Integrase and Ran in his Importin study. His Cell biology research is multidisciplinary, incorporating elements of Perforin, Granzyme and Granzyme B. His research in Biochemistry tackles topics such as Biophysics which are related to areas like Cell culture.

His most cited work include:

  • The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. (719 citations)
  • Nuclear targeting signal recognition: a key control point in nuclear transport? (487 citations)
  • Towards safe, non-viral therapeutic gene expression in humans (475 citations)

What are the main themes of his work throughout his whole career to date?

Nuclear transport, Cell biology, Importin, Nuclear localization sequence and Molecular biology are his primary areas of study. His Nuclear transport study combines topics from a wide range of disciplines, such as Nuclear export signal, Nuclear protein and NLS. The various areas that David A. Jans examines in his Cell biology study include Genetics and Transcription factor.

His Importin research is multidisciplinary, relying on both Beta Karyopherins, Virology, Dengue virus, Ran and Importin-alpha. His study in Nuclear localization sequence is interdisciplinary in nature, drawing from both Green fluorescent protein, Fusion protein, Phosphorylation, Subcellular localization and Binding site. His studies in Molecular biology integrate themes in fields like Cell culture, Protein kinase A and Protein subunit, Gene, Mutant.

He most often published in these fields:

  • Nuclear transport (56.36%)
  • Cell biology (52.73%)
  • Importin (40.91%)

What were the highlights of his more recent work (between 2014-2021)?

  • Virology (18.18%)
  • Nuclear transport (56.36%)
  • Importin (40.91%)

In recent papers he was focusing on the following fields of study:

David A. Jans mainly focuses on Virology, Nuclear transport, Importin, Cell biology and Virus. The concepts of his Nuclear transport study are interwoven with issues in Nuclear export signal, Molecular biology, Nuclear localization sequence and Transporter. His research on Nuclear localization sequence concerns the broader Biochemistry.

In his research on the topic of Importin, Beta Karyopherins is strongly related with Alpha Karyopherins. Within one scientific family, David A. Jans focuses on topics pertaining to Nuclear protein under Cell biology, and may sometimes address concerns connected to Interactome. David A. Jans studied Virus and Mitochondrion that intersect with Reactive oxygen species.

Between 2014 and 2021, his most popular works were:

  • The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. (719 citations)
  • The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer (104 citations)
  • Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import (82 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

David A. Jans spends much of his time researching Virology, Nuclear transport, Importin, Cell biology and Viral replication. His work in the fields of Virology, such as Virus and 2019-20 coronavirus outbreak, intersects with other areas such as Ivermectin and Initiation factor. His Virus study combines topics in areas such as Inflammation and Outbreak.

His Nuclear transport study combines topics in areas such as Nuclear export signal, RNA, Nuclear localization sequence and Dengue virus. His Importin study incorporates themes from Transport protein, Receptor and Transporter. His research on Cell biology frequently connects to adjacent areas such as Spermatogenesis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Leon Caly;Julian D. Druce;Mike G. Catton;David A. Jans.
Antiviral Research (2020)

1133 Citations

Towards safe, non-viral therapeutic gene expression in humans

Dominic J Glover;Hans J Lipps;David Andrew Jans;David Andrew Jans.
Nature Reviews Genetics (2005)

720 Citations

Nuclear targeting signal recognition: a key control point in nuclear transport?

David A. Jans;Chong Yun Xiao;Mark H C Lam.
BioEssays (2000)

673 Citations

Regulation of protein transport to the nucleus: Central role of phosphorylation

David A. Jans;Stefan Hübner.
Physiological Reviews (1996)

520 Citations

The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen.

Hans Peter Rihs;David A. Jans;Hua Fan;Reiner Peters.
The EMBO Journal (1991)

432 Citations

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus.

Kylie M. Wagstaff;Haran Sivakumaran;Steven M. Heaton;David Harrich.
Biochemical Journal (2012)

422 Citations

Regulation of Nuclear Transport: Central Role in Development and Transformation?

Ivan K H Poon;David Andrew Jans;David Andrew Jans.
Traffic (2005)

408 Citations

Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit

Lynette J. Schedlich;Sophie L. Le Page;Sue M. Firth;Lyndall J. Briggs.
Journal of Biological Chemistry (2000)

341 Citations

An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Ann-Maree Catanzariti;Tatiana A. Soboleva;David A. Jans;David A. Jans;Philip G. Board.
Protein Science (2004)

325 Citations

The protein kinase CK2 site (Ser111/112) enhances recognition of the simian virus 40 large T-antigen nuclear localization sequence by importin.

Stefan Hübner;Chong Yun Xiao;David A. Jans.
Journal of Biological Chemistry (1997)

292 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David A. Jans

Joseph A. Trapani

Joseph A. Trapani

Peter MacCallum Cancer Centre

Publications: 67

Yoshihiro Yoneda

Yoshihiro Yoneda

Osaka University

Publications: 51

Kate L Loveland

Kate L Loveland

Hudson Institute of Medical Research

Publications: 47

Subhash G. Vasudevan

Subhash G. Vasudevan

Duke NUS Graduate Medical School

Publications: 40

Phillip I. Bird

Phillip I. Bird

Monash University

Publications: 39

Elizabeth L. Hartland

Elizabeth L. Hartland

Hudson Institute of Medical Research

Publications: 31

Bostjan Kobe

Bostjan Kobe

University of Queensland

Publications: 30

Judy Lieberman

Judy Lieberman

Boston Children's Hospital

Publications: 27

Hideyoshi Harashima

Hideyoshi Harashima

Hokkaido University

Publications: 26

Julien Lescar

Julien Lescar

Nanyang Technological University

Publications: 26

Vincent R. Harley

Vincent R. Harley

Hudson Institute of Medical Research

Publications: 24

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 24

Anita H. Corbett

Anita H. Corbett

Emory University

Publications: 24

Philip G. Board

Philip G. Board

Australian National University

Publications: 23

Robert C. Baxter

Robert C. Baxter

Royal North Shore Hospital

Publications: 21

Christopher J. Froelich

Christopher J. Froelich

NorthShore University HealthSystem

Publications: 21

Trending Scientists

Kai Keng Ang

Kai Keng Ang

A*STAR - Agency for Science, Technology and Research

Marly Monteiro de Carvalho

Marly Monteiro de Carvalho

Universidade de São Paulo

Geoffrey B. Rhoads

Geoffrey B. Rhoads

Digimarc (United States)

Vladimir Pavlovic

Vladimir Pavlovic

Rutgers, The State University of New Jersey

Hiroshi Nagase

Hiroshi Nagase

University of Tsukuba

Shinzo Kohjiya

Shinzo Kohjiya

Kyoto University

Marcelo B. Soares

Marcelo B. Soares

University of Illinois at Peoria

Sashwati Roy

Sashwati Roy

Indiana University

Heymut Omran

Heymut Omran

University of Münster

Roy W. Schlische

Roy W. Schlische

Rutgers, The State University of New Jersey

Robert D. Nebes

Robert D. Nebes

University of Pittsburgh

Karl Rickels

Karl Rickels

University of Pennsylvania

Antonio Daniele Pinna

Antonio Daniele Pinna

University of Bologna

David C. Thomas

David C. Thomas

University of Victoria

Andrea Comastri

Andrea Comastri

National Institute for Astrophysics

Gunnar Løvhøiden

Gunnar Løvhøiden

University of Oslo

Something went wrong. Please try again later.